Skip to content
Tenfell
Awarded contract
Published 17 Oct 2024

NHS National Framework for Transition products commencing 1 October 2024

NHS England · London

Key facts

Awarded
29 Sep 2024
Contract starts
30 Sep 2024
Contract ends
31 May 2026
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 12 suppliers

SupplierValue
Celix Pharma Ltd.—
Dr Reddy's Laboratories (UK) Ltd—
Teva UK Ltd—
Thornton & Ross Ltd—
Accord-UK Ltd—
Gilead Sciences Limited—
Zentiva Pharma UK Ltd—
Amarox Limited—
Tillomed Laboratories ltd—
Glenmark Pharmaceuticals Europe Ltd—
Mercury Pharmaceuticals Limited—
Seacross Pharmaceuticals Ltd—

Description

Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement:

CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)

CM/TNS/24/5712/02 - Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.